EichorEICHOR
Condition: Pharmacokinetics And Pharmacodynamics Synced from ClinicalTrials.gov · August 10, 2026

Recruiting studies: Pharmacokinetics And Pharmacodynamics

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · 40 location(s) · Alexion Pharmaceuticals, Inc. · NCT07157787A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · 8 location(s) · Erasca, Inc. · NCT06983743PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE
Phase N/A · 2 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06717594This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · 341 location(s) · Pfizer · NCT07028853A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants
Phase 1 · 1 location(s) · Septerna, Inc. · NCT07433179A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Phase 1/Phase 2 · 4 location(s) · Spirovant Sciences, Inc. · NCT06526923Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies
Phase 1 · 1 location(s) · CytoCares Inc · NCT06037018A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
Phase 1/Phase 2 · 1 location(s) · Ascentage Pharma Group Inc. · NCT06182969A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · 47 location(s) · Astellas Pharma Global Development, Inc. · NCT05970172Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · 50 location(s) · Walden Biosciences · NCT06466135An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Phase 1/Phase 2 · 5 location(s) · Pathios Therapeutics Pty Ltd · NCT06634849A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With
Phase 1/Phase 2 · 14 location(s) · Hoffmann-La Roche · NCT05987449Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
EARLY_Phase 1 · 4 location(s) · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05145361First in Human Study in Subjects With Obesity, But Otherwise Healthy
Phase 1 · 1 location(s) · NeuroBo Pharmaceuticals Inc. · NCT06252220A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors
Phase 1 · 1 location(s) · Hefei TG ImmunoPharma Co., Ltd. · NCT06374173A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Com
Phase 1/Phase 2 · 14 location(s) · AstraZeneca · NCT06188520A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Phase 1 · 1 location(s) · Hanmi Pharmaceutical Company Limited · NCT07219589Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01441089A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects
Phase 1 · 1 location(s) · Shanghai Hengrui Pharmaceutical Co., Ltd. · NCT07301333Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Phase 1 · 15 location(s) · TRex Bio, Inc. · NCT06934252Clinical Study of Cizutamig in Systemic Lupus Erythematosus
Phase 1 · 1 location(s) · Candid Therapeutics · NCT07215663SAR447971 First-in-human Study
Phase 1 · 1 location(s) · Sanofi · NCT07629336A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Phase 1 · 9 location(s) · Myeloid Therapeutics · NCT06478693Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy V
Phase 1 · 1 location(s) · Daewoong Pharmaceutical Co. LTD. · NCT06736587Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects
Phase 1 · 1 location(s) · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07535099A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Pa
Phase 1 · 1 location(s) · Zealand Pharma · NCT06682975A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors
Phase 1 · 4 location(s) · Suzhou Genhouse Bio Co., Ltd. · NCT06796699A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Phase 1/Phase 2 · 14 location(s) · Vico Therapeutics B. V. · NCT05822908A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · 25 location(s) · Hemab ApS · NCT06754852Comparison of the Pharmacokinetics （PK）and Pharmacodynamics （PD）Biosimilarity of Insulin Aspart Injections After Single-
NA · 1 location(s) · Zhuhai United Laboratories Co., Ltd. · NCT07600944
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.